Julie A. Vetalice, Author at ORTHOWORLD

Ortho RTI Partners to Study Ortho-R Biopolymer Matrix

Ortho Regenerative Technologies entered into an agreement to evaluate a commercial product from an unnamed orthopedic company partner for use with Ortho's Ortho-R biopolymer matrix.

Aug 28, 2019

Onkos Surgical to Distribute OsteoCrete Bone Void Filler

Company Updates Competitive Landscape

Onkos Surgical will market Bone Solutions' OsteoCrete® magnesium-based bone void filler under the GenVie brand through a private label agreement.

Aug 28, 2019

Omar Ishrak to Retire as CEO of Medtronic

Company Updates Competitive Landscape

Medtronic Chief Executive Officer Omar Ishrak announced his intention to retire in the beginning of 2Q20. Geoff Martha, currently Executive Vice President of MDT's Restorative Therapies Group, will assume the newly-created role of Medtronic President in 4Q19 and succeed Ishrak as CEO next year.

Aug 28, 2019

Ozop Surgical Enters into License Agreement with Spinal Resources

Company Updates Competitive Landscape

Ozop Surgical entered into an exclusive license agreement to sell various products from Spinal Resources.

Aug 27, 2019

Fuse Medical Launches Sterizo Total Knee

Joint Replacement ORTHOFLASH

Fuse Medical introduced the Sterizo Total Knee, with multiple stabilization options including Cruciate Retained, Ultra Congruent Anterior Stabilized and Posterior Stabilized.

Aug 26, 2019

DiscGenics Receives FDA Fast Track Designation for Cell Therapy

Orthobiologics ORTHOFLASH

DiscGenics was granted Fast Track designation from FDA for its investigational cell therapy, IDCT, under evaluation in clinical trials in the U.S. and Japan to treat pain and disability from degenerative disc disease.

Aug 26, 2019